Top 100 Contractors in PSC 6505: Drugs and Biologicals, FY2024

Parent companies by net contract obligations Oct 1, 2023 – Sep 30, 2024 Code page on GovTribe

The top 10 won 94% of FY2024 PSC 6505 contract dollars

Ranking facts

Contract obligations
$17,103,583,086 Net of deobligations, by contracts coded PSC 6505
Contractors
560 Parent companies with an obligation
Largest contractor
McKesson Corporation $8.96 billion, 51.7% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $8,961,877,345
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2023 and #1 in FY2025; unchanged since FY2023.
2 $4,292,768,361
Rank history: #5 in FY2021, #6 in FY2022, #3 in FY2023 and #2 in FY2025; up 1 since FY2023.
3 $1,731,086,854
Rank history: not on the FY2021 list, #8 in FY2022, #2 in FY2023 and not on the FY2025 list; down 1 since FY2023.
4
Roche Diabetes Care Inc Through Genentech Usa, Inc.
$396,999,520
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 410 since FY2023.
5 $251,721,023
Rank history: #10 in FY2021, #10 in FY2022, #5 in FY2023 and #3 in FY2025; unchanged since FY2023.
6 $222,920,840
Rank history: #13 in FY2021, #9 in FY2022, #8 in FY2023 and #5 in FY2025; up 2 since FY2023.
7 $153,322,720
Rank history: not on the FY2021–FY2023 lists and #48 in FY2025; new.
8 $122,975,784
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
9 $89,156,039
Rank history: #20 in FY2021, #18 in FY2022, #9 in FY2023 and #8 in FY2025; unchanged since FY2023.
10 $69,164,064
Rank history: not on the FY2021–FY2023 lists and #11 in FY2025; new.
11 $62,162,037
Rank history: #8 in FY2021, #5 in FY2022, #45 in FY2023 and #18 in FY2025; up 34 since FY2023.
12
Alvogen Group Inc. Through Alvogen, Inc.
$57,099,988
Rank history: not on the FY2021–FY2023 lists and #4 in FY2025; new.
13 $32,940,012
Rank history: not on the FY2021–FY2022 lists, #35 in FY2023 and #25 in FY2025; up 22 since FY2023.
14 $32,713,775
Rank history: not on the FY2021–FY2023 lists and #14 in FY2025; new.
15 $32,143,410
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 348 since FY2023.
16 $31,219,000
Rank history: not on the FY2021 list, #25 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
17 $31,049,271
Rank history: #31 in FY2021, #27 in FY2022, #13 in FY2023 and #17 in FY2025; down 4 since FY2023.
18 $26,676,694
Rank history: not on the FY2021–FY2023 lists and #27 in FY2025; new.
19 $26,076,060
Rank history: not on the FY2021 list, #38 in FY2022, #17 in FY2023 and #16 in FY2025; down 2 since FY2023.
20 $26,059,075
Rank history: #21 in FY2021, #23 in FY2022, #10 in FY2023 and #28 in FY2025; down 10 since FY2023.
21 $25,692,481
Rank history: #25 in FY2021, not on the FY2022–FY2023 lists and #36 in FY2025; returned.
22 $23,031,995
Rank history: #18 in FY2021, #28 in FY2022, #27 in FY2023 and not on the FY2025 list; up 5 since FY2023.
23 $22,524,097
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 406 since FY2023.
24 $21,808,359
Rank history: #45 in FY2021, #48 in FY2022, #18 in FY2023 and not on the FY2025 list; down 6 since FY2023.
25
Emergent Biosolutions Inc. Through Emergent Biodefense Operations Lansing LLC
$20,999,810
Rank history: not on the FY2021–FY2023 lists and #6 in FY2025; new.
26 $18,279,236
Rank history: #26 in FY2021, not on the FY2022 list, #11 in FY2023 and #44 in FY2025; down 15 since FY2023.
27 $16,297,404
Rank history: not on the FY2021–FY2023 lists and #21 in FY2025; new.
28 $15,665,352
Rank history: #41 in FY2021, #33 in FY2022, #20 in FY2023 and #22 in FY2025; down 8 since FY2023.
29 $15,089,087
Rank history: #28 in FY2021, #30 in FY2022, #19 in FY2023 and not on the FY2025 list; down 10 since FY2023.
30 $14,958,069
Rank history: #43 in FY2021, #43 in FY2022, not on the FY2023 list and #93 in FY2025; returned.
31 $13,877,121
Rank history: not on the FY2021–FY2023 lists and #24 in FY2025; new.
32 $13,113,220
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
33 $10,112,508
Rank history: not on the FY2021–FY2023 lists and #40 in FY2025; up 196 since FY2023.
34 $10,091,475
Rank history: not on the FY2021 list, #35 in FY2022, #37 in FY2023 and not on the FY2025 list; up 3 since FY2023.
35
Dakco Distributors Inc. Through Dakota Drug, Inc.
$9,256,454
Rank history: #40 in FY2021, #41 in FY2022, #30 in FY2023 and not on the FY2025 list; down 5 since FY2023.
36 $7,922,892
Rank history: #94 in FY2021, #42 in FY2022, #29 in FY2023 and not on the FY2025 list; down 7 since FY2023.
37
Boehringer Ingelheim Animal Health USA Inc
$7,683,804
Rank history: not on the FY2021–FY2022 lists, #36 in FY2023 and #37 in FY2025; down 1 since FY2023.
38
Zoll Medical Corporation
$7,146,879
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
39 $7,129,105
Rank history: #38 in FY2021, #46 in FY2022, #21 in FY2023 and not on the FY2025 list; down 18 since FY2023.
40
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$5,802,481
Rank history: #22 in FY2021, #24 in FY2022, #12 in FY2023 and not on the FY2025 list; down 28 since FY2023.
41 $5,753,689
Rank history: #42 in FY2021, #47 in FY2022, #26 in FY2023 and #46 in FY2025; down 15 since FY2023.
42 $5,594,103
Rank history: #64 in FY2021, #82 in FY2022, #22 in FY2023 and not on the FY2025 list; down 20 since FY2023.
43 $5,335,318
Rank history: not on the FY2021–FY2023 lists and #33 in FY2025; new.
44 $5,299,988
Rank history: not on the FY2021 list, #50 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
45 $5,025,000
Rank history: not on the FY2021–FY2023 lists and #49 in FY2025; new.
46 $4,314,182
Rank history: #71 in FY2021, #85 in FY2022, #39 in FY2023 and #41 in FY2025; down 7 since FY2023.
47 $4,303,359
Rank history: #58 in FY2021, #55 in FY2022, #40 in FY2023 and #39 in FY2025; down 7 since FY2023.
48 $3,855,812
Rank history: #50 in FY2021, #63 in FY2022, #42 in FY2023 and not on the FY2025 list; down 6 since FY2023.
49 $3,749,838
Rank history: #51 in FY2021, #71 in FY2022, #31 in FY2023 and not on the FY2025 list; down 18 since FY2023.
50 $3,716,311
Rank history: #56 in FY2021, #49 in FY2022, #38 in FY2023 and #57 in FY2025; down 12 since FY2023.
51 $3,593,177
Rank history: #54 in FY2021, #45 in FY2022, #15 in FY2023 and not on the FY2025 list; down 36 since FY2023.
52 $3,539,541
Rank history: #57 in FY2021, #60 in FY2022, #50 in FY2023 and #47 in FY2025; down 2 since FY2023.
53 $3,516,105
Rank history: #37 in FY2021, #51 in FY2022, #47 in FY2023 and #72 in FY2025; down 6 since FY2023.
54 $3,136,164
Rank history: #76 in FY2021, #64 in FY2022, #46 in FY2023 and #59 in FY2025; down 8 since FY2023.
55 $3,133,081
Rank history: not on the FY2021–FY2023 lists and #38 in FY2025; new.
56 $3,106,500
Rank history: not on the FY2021–FY2022 lists, #90 in FY2023 and #55 in FY2025; up 34 since FY2023.
57 $2,929,036
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 48 since FY2023.
58 $2,848,491
Rank history: #84 in FY2021, #68 in FY2022, #52 in FY2023 and not on the FY2025 list; down 6 since FY2023.
59 $2,600,871
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
60
Meridian Medical Technologies LLC
$2,495,170
Rank history: not on the FY2021–FY2023 lists and #85 in FY2025; new.
61 $2,486,413
Rank history: not on the FY2021–FY2023 lists and #29 in FY2025; new.
62 $2,427,889
Rank history: #46 in FY2021, #39 in FY2022, not on the FY2023 list and #67 in FY2025; returned.
63 $2,300,986
Rank history: not on the FY2021–FY2023 lists and #52 in FY2025; new.
64 $2,286,190
Rank history: #62 in FY2021, #86 in FY2022, #98 in FY2023 and not on the FY2025 list; up 34 since FY2023.
65 $2,242,678
Rank history: not on the FY2021–FY2022 lists, #53 in FY2023 and not on the FY2025 list; down 12 since FY2023.
66 $2,228,527
Rank history: #52 in FY2021, #59 in FY2022, #96 in FY2023 and not on the FY2025 list; up 30 since FY2023.
67 $2,197,774
Rank history: #97 in FY2021, #90 in FY2022, #77 in FY2023 and not on the FY2025 list; up 10 since FY2023.
68 $2,185,359
Rank history: not on the FY2021–FY2022 lists, #79 in FY2023 and #64 in FY2025; up 11 since FY2023.
69 $2,098,500
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
70 $2,020,817
Rank history: #98 in FY2021, #93 in FY2022, #63 in FY2023 and not on the FY2025 list; down 7 since FY2023.
71 $1,975,190
Rank history: #80 in FY2021, #80 in FY2022, #55 in FY2023 and #84 in FY2025; down 16 since FY2023.
72 $1,847,407
Rank history: not on the FY2021–FY2023 lists and #62 in FY2025; new.
73 $1,822,233
Rank history: #79 in FY2021, not on the FY2022 list, #66 in FY2023 and not on the FY2025 list; down 7 since FY2023.
74
Henry Schein Inc. Through North American Rescue, LLC
$1,764,318
Rank history: not on the FY2021–FY2023 lists and #50 in FY2025; new.
75 $1,755,779
Rank history: #66 in FY2021, #81 in FY2022, #59 in FY2023 and #88 in FY2025; down 16 since FY2023.
76 $1,709,644
Rank history: not on the FY2021 list, #61 in FY2022, not on the FY2023 list and #66 in FY2025; returned.
77 $1,688,407
Rank history: not on the FY2021 list, #88 in FY2022, #81 in FY2023 and not on the FY2025 list; up 4 since FY2023.
78 $1,675,276
Rank history: not on the FY2021–FY2022 lists, #82 in FY2023 and not on the FY2025 list; up 4 since FY2023.
79 $1,637,384
Rank history: not on the FY2021–FY2023 lists and #100 in FY2025; new.
80 $1,606,366
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 29 since FY2023.
81 $1,597,292
Rank history: #48 in FY2021, #52 in FY2022, #51 in FY2023 and #83 in FY2025; down 30 since FY2023.
82 $1,494,571
Rank history: not on the FY2021–FY2023 lists and #97 in FY2025; new.
83 $1,474,677
Rank history: #86 in FY2021, #65 in FY2022, #44 in FY2023 and #56 in FY2025; down 39 since FY2023.
84 $1,447,551
Rank history: #72 in FY2021, #70 in FY2022, #61 in FY2023 and #71 in FY2025; down 23 since FY2023.
85
Alexion Pharmaceuticals Inc 2 awardees
$1,441,918
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
86 $1,438,308
Rank history: not on the FY2021 list, #91 in FY2022, not on the FY2023 list and not on the FY2025 list; up 95 since FY2023.
87
Medtronic Public Limited Company 2 awardees, including Medtronic Inc. and Medtronic USA Inc.
$1,405,713
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 206 since FY2023.
88 $1,403,297
Rank history: not on the FY2021 list, #78 in FY2022, #73 in FY2023 and #77 in FY2025; down 15 since FY2023.
89 $1,341,218
Rank history: #74 in FY2021, not on the FY2022 list, #60 in FY2023 and not on the FY2025 list; down 29 since FY2023.
90 $1,307,972
Rank history: not on the FY2021–FY2023 lists and #79 in FY2025; up 137 since FY2023.
91 $1,196,927
Rank history: #73 in FY2021, #95 in FY2022, #71 in FY2023 and #45 in FY2025; down 20 since FY2023.
92 $1,183,545
Rank history: not on the FY2021–FY2022 lists, #80 in FY2023 and not on the FY2025 list; down 12 since FY2023.
93 $1,133,332
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
94 $1,036,175
Rank history: #96 in FY2021, not on the FY2022–FY2023 lists and #94 in FY2025; up 147 since FY2023.
95
Heyltex Corporation
$1,021,469
Rank history: not on the FY2021–FY2022 lists, #43 in FY2023 and not on the FY2025 list; down 52 since FY2023.
96 $996,416
Rank history: #82 in FY2021, #89 in FY2022, #78 in FY2023 and not on the FY2025 list; down 18 since FY2023.
97 $978,666
Rank history: not on the FY2021–FY2022 lists, #100 in FY2023 and not on the FY2025 list; up 3 since FY2023.
98 $938,112
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 21 since FY2023.
99 $900,489
Rank history: not on the FY2021 list, #72 in FY2022, #48 in FY2023 and not on the FY2025 list; down 51 since FY2023.
100 $877,885
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
Show 75 more

100 of 560 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $17.3 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2024 ran Oct 1, 2023 – Sep 30, 2024. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2023. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2023 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 6505 contractors in FY2024?

1. McKesson Corporation ($8.96B), 2. Cencora, Inc. ($4.29B), 3. Amerisourcebergen Corporation ($1.73B), 4. Roche Diabetes Care Inc ($397M), 5. DMS Pharmaceutical Group Inc. ($252M), 6. Bavarian Nordic A / S ($223M), 7. Merck & Co. Inc. ($153M), 8. Emergent Biosolutions Canada Inc. ($123M), 9. Government of the United States ($89.2M), 10. Nighthawk Biosciences, Inc. ($69.2M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work